Ensuring Balance in national policies on controlled substances, guidance for availability and accessibility of controlled medicines
To evaluate policies and regulations in countries with insufficient access to controlled medicines such as opioid analgesics, or opioids to treat dependence (= most countries)
- Sub-categories Assessments and Research, HIV/AIDS, Noncommunicable diseases (NCD), Reproductive health
- Commodities Medicines
- Latest update 2016-03-15 20:11:00
- Version 1
- Developed by World Health Organization (Dept EMP)
- When to use To evaluate policies and regulations in countries with insufficient access to controlled medicines such as opioid analgesics, or opioids to treat dependence (= most countries)
- Languages English, French, Russian, Spanish
- Level of use Central
- Form Introduction with explication of barriers for access to medicines controlled under the drug control conventions: 1. regulations and policies, 2. knowledge 3. attitudes and 4. economic and procurement. Then 21 guidelines on these barriers with examples of
- Amount of training / TA required None; though good understanding of how public administration works is helpful.
- Inputs & outputs Working on the checklist with a team with members from the administration and field experts will be the best way to make the assessment from the checklist. This will result in a comprehensive overview of the barriers.
- Cost All language versions: free download. Hard copies (English, French and Spanish only): CHF 25.00 / US$ 30.00 Developing countries: CHF 17.50
- Advantages This is an essential tool to overcome the situation that 2/3 of the world pèopulation has no access to adequate management of pain.
- Limitations Work load
- Availability Yes. Please see: http://www.who.int/medicines/areas/quality_safety/guide_nocp_sanend/en/
- Remarks I am submitting this as the former responsible person in WHO who developed these guidelines. Please see http://www.who.int/medicines/areas/quality_safety/guide_nocp_sanend/en/
- Contact firstname.lastname@example.org; email@example.com
- Submission date 2016-03-15 02:00:00